BDBM351934 US9802904, 66
SMILES: CC(C)c1ccccc1-c1nc(C)c(C)c(NCc2ccc(cc2)-c2ccccc2)n1
InChI Key: InChIKey=ZNJXHHPWNNHGRG-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
USP1/UAF1 (Homo sapiens (Human)) | BDBM351934 (US9802904, 66) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
The United States of America, as represented by the Secretary, Department of Health and Human Services; University of Delaware US Patent | Assay Description This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ... | US Patent US9802904 (2017) BindingDB Entry DOI: 10.7270/Q2TF00H8 | |||||||||||
More data for this Ligand-Target Pair |